Rounds
Every Reg CF and Reg A+ raise, ranked on the same daily numbers whichever platform it's on.
Showing 426–450 of 528 · Open now · 7-day change is shown where we have a daily snapshot from a week ago
| Company | Round | Platform | Raised | 7 days | Valuation | Dates |
|---|---|---|---|---|---|---|
Regen BioPharma Inc Biotech | Open Reg A+ · Equity | — | $35K 4% of $1M | — | $532K Estimated pre-money | Opened Dec 3, 2025 |
BridgeWell Secured Income LP Real Estate | Open Reg A+ · Equity | — | $0 0% of $75M | — | $7.8M Estimated pre-money | Opened Jun 4, 2026 |
Mightylicious Food & Beverage | Open Reg CF · SAFE | Republic | $6K 1% of $1M · 17 investors | — | $5M Valuation cap | Opened Sep 28, 2026 Deadline Dec 18, 2026 |
![]() EnergyX Industrial & Manufacturing | Open Reg A+ · Equity | DealMaker | $0 0% of $25.1M | — | $2.6B Post-money valuation | Opened Jul 1, 2025 |
CESL SITE 2 LLC Energy & Cleantech | Open Reg CF · Debt | CLIMATIZE EARTH SECURITIES LLC | $0 0% of $500K | — | — | Opened Aug 5, 2026 Deadline Nov 3, 2026 |
![]() Satschel, Inc Uncategorized | Open Reg CF · Common Equity | LIQUIDITY.IO, LLC | $0 | — | — | Opened Sep 9, 2026 Deadline Sep 1, 2027 |
Software Effective Solutions, Corp. Software & AI | Open Reg A+ · Equity | — | $0 0% of $4.5M | — | $42.7M Estimated pre-money | Opened Jun 6, 2025 |
Nextel Medical Corp. Software & AI | Open Reg A+ · Equity | — | $0 0% of $3.8M | — | $6M Estimated pre-money | Opened Sep 8, 2025 |
Niihara International, Inc. Biotech | Open Reg A+ · Equity | — | $0 0% of $20M | — | $290.3M Estimated pre-money | Opened Feb 6, 2026 |
BLUEMOUNT INTERNATIONAL INC Uncategorized | Open Reg A+ · Equity | — | $0 0% of $1M | — | $5M Estimated pre-money | Opened Sep 1, 2026 |
Infinity Fuel Cell & Hydrogen, Inc. Energy & Cleantech | Open Reg CF · Common Equity | DealMaker | $225.8K 5% of $5M · 121 investors | — | $65.8M Post-money valuation | Opened Sep 9, 2026 Deadline Mar 26, 2027 |
Dome Capital, LLC Real Estate | Open Reg A+ · Equity | — | $0 0% of $197.8K | — | — | Opened Jul 2, 2025 |
![]() GoSun Biotech | Open Reg CF · Common Equity | StartEngine | $63.5K 2% of $3.7M · 38 investors | — | $56.9M Post-money valuation | Opened Sep 30, 2026 Deadline Dec 29, 2026 |
![]() R&I Management Diversified, Inc Uncategorized | Open Reg CF · Common Equity | ANDES CAPITAL GROUP, LLC | $0 0% of $1.2M | — | — | Opened May 1, 2026 Deadline Apr 30, 2027 |
PRC Equity Fund I, LLC Real Estate | Open Reg A+ · Equity | — | $0 0% of $75M | — | — | Opened Oct 4, 2024 |
Unified Solutions America, Inc. Software & AI | Open Reg CF · Common Equity | Equity St. Portal LLC | $0 0% of $5M | — | — | Opened Jan 30, 2026 Deadline Jan 18, 2027 |
![]() Acorn Genetics Biotech | OpenEarly bird Reg CF · SAFE | StartEngine | $0 0% of $1.2M · 0 investors | — | $25M Valuation cap | Opened Sep 28, 2026 Deadline Dec 28, 2026 |
![]() BIO-PATH HOLDINGS, INC. Biotech | Open Reg A+ · Equity | — | $0 0% of $600K | — | $280.3K Estimated pre-money | Opened Apr 28, 2026 |
Masterworks Vault 15, LLC Alternative Assets | Open Reg A+ · Equity | — | $0 0% of $70.5M | — | $70.7M Estimated pre-money | Opened May 29, 2026 |
MUSAFFA Fintech | Open Reg CF · Common Equity | DealMaker | $0 0% of $1.2M | — | $125.8M Estimated pre-money | Opened Jun 12, 2026 Deadline Dec 31, 2026 |
SMB Systems Integrators Inc Media & Entertainment | Open Reg A+ · Equity | — | $0 0% of $4M | — | $11M Estimated pre-money | Opened Dec 31, 2025 |
![]() Clarify AI, Inc. Software & AI | Open Reg CF · Common Equity | ANDES CAPITAL GROUP, LLC | $0 0% of $1.2M | — | — | Opened Sep 25, 2026 Deadline Dec 31, 2026 |
![]() String Cubed Inc Uncategorized | Open Reg CF · Common Equity | DealMaker | $82.8K 2% of $5M · 59 investors | — | — | Opened Sep 30, 2026 Deadline Jun 1, 2027 |
![]() Paj Turnervision Production LLC Media & Entertainment | Open Reg CF · Revenue Share | CineBlockFilms, LLC | $0 0% of $5M | — | — | Opened Jun 2, 2026 Deadline Nov 26, 2026 |
GenAI Works, Inc. Software & AI | Open Reg CF · Common Equity | DealMaker | $519.1K 11% of $4.7M | — | — | Opened Jul 16, 2025 Deadline Apr 30, 2027 |








